1. Annual Data Report. USRDS. https://usrds-adr.niddk.nih.gov/. Accessed July 22, 2025.
2. Rooijens PPGM, Tordoir JHM, Stijnen T, et al. Radiocephalic wrist arteriovenous fistula for hemodialysis: meta-analysis indicates a high primary failure rate. Eur J Vasc Endovasc Surg. 2004;28(6):583-589. doi: 10.1016/j.ejvs.2004.08.014
3. Roy-Chaudhury P, Sukhatme VP, Cheung AK. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol. 2006;17(4):1112-1127. doi:10.1681/ASN.2005050615
4. Hayashi R, Huang E, Nissenson AR. Vascular access for hemodialysis. Nat Clin Pract Nephrol. 2006;2(9):504-513. doi:10.1038/ncpneph0239
5. Stolic R. Most important chronic complications of arteriovenous fistulas for hemodialysis. Med Princ Pract. 2013;22(3):220-228. doi:10. 1159/000343669
6. Bojakowski K, Dzabic M, Kurzejamska E, et al. A high red blood cell distribution width predicts failure of arteriovenous fistula. PLoS One. 2012;7(5):e36482. doi:10.1371/journal.pone.0036482
7. Bashar K, Zafar A, Ahmed K, et al. Can a neutrophil-lymphocyte ratio derived from preoperative blood tests predict arteriovenous fistula maturation? Ann Vasc Surg. 2016;35:60-67. doi:10.1016/j.avsg.2016.02.020
8. Lee T, Barker J, Allon M. Tunneled catheters in hemodialysis patients: reasons and subsequent outcomes. Am J Kidney Dis. 2005;46(3):501-508. doi:10.1053/j.ajkd.2005.05.024
9. Chiulli LC, Vasilas P, Dardik A. Superior patency of upper arm arteriovenous fistulae in high risk patients. J Surg Res. 2011;170(1):157-164. doi:10.1016/j.jss.2011.03.042
10. Mozaffar M, Fallah M, Lotfollahzadeh S, et al. Comparison of efficacy of side to side versus end to side arteriovenous fistulae formation in chronic renal failure as a permanent hemodialysis access. Nephrourol Mon. 2013;5(3):827-830. doi:10.5812/numonthly.10248
11. Schinstock CA, Albright RC, Williams AW, et al. Outcomes of arteriovenous fistula creation after the Fistula First Initiative. Clin J Am Soc Nephrol. 2011;6(8):1996-2002. doi:10.2215/CJN.11251210
12. Al-Jaishi AA, Oliver MJ, Thomas SM, et al. Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2014;63(3):464-478. doi:10.1053/j.ajkd.2013. 08.023
13. Irish A, Dogra G, Mori T, et al. Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and aspirin in vascular access outcomes in renal disease (FAVOURED) study. BMC Nephrol. 2009;10:1. doi:10.1186/1471-2369-10-1
14. Lazarides MK, Georgiadis GS, Antoniou GA, Staramos DN. A meta-analysis of dialysis access outcome in elderly patients. J Vasc Surg. 2007; 45(2):420-426. doi:10.1016/j.jvs.2006.10.035
15. Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int. 2002;61(1): 305-316. doi:10.1046/j.1523-1755.2002.00117.x
16. Lok CE, Oliver MJ, Su J, Bhola C, Hannigan N, Jassal SV. Arteriovenous fistula outcomes in the era of the elderly dialysis population. Kidney Int. 2005;67(6):2462-2469. doi:10.1111/j.1523-1755.2005.00355.x
17. Swindlehurst N, Swindlehurst A, Lumgair H, et al. Vascular access for hemodialysis in the elderly. J Vasc Surg. 2011;53(4):1039-1043. doi:10. 1016/j.jvs.2010.09.068
18. Weale AR, Bevis P, Neary WD, et al. Radiocephalic and brachiocephalic arteriovenous fistula outcomes in the elderly. J Vasc Surg. 2008;47(1):144-150. doi:10.1016/j.jvs.2007.09.046
19. Astor BC, Coresh J, Powe NR, Eustace JA, Klag MJ. Relation between gender and vascular access complications in hemodialysis patients. Am J Kidney Dis. 2000;36(6):1126-1134. doi:10.1053/ajkd.2000.19816
20. Sedlacek M, Teodorescu V, Falk A, Vassalotti JA, Uribarri J. Hemodialysis access placement with preoperative noninvasive vascular mapping: comparison between patients with and without diabetes. Am J Kidney Dis. 2001;38(3):560-564. doi:10.1053/ajkd.2001.26873
21. Konner K, Hulbert-Shearon TE, Roys EC, Port FK. Tailoring the initial vascular access for dialysis patients. Kidney Int. 2002;62(1):329-338. doi: 10.1046/j.1523-1755.2002.00436.x
22. Kordzadeh A, Chung J, Panayiotopoulos YP. Cephalic vein and radial artery diameter in formation of radiocephalic arteriovenous fistula: a systematic review. J Vasc Access. 2015;16(6):506-511. doi:10.5301/jva. 5000413
23. Aronson D, Bloomgarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol. 1996;27(3): 528-535. doi:10.1016/0735-1097(95)00496-3
24. Marrone D, Pertosa G, Simone S, et al. Local activation of interleukin 6 signaling is associated with arteriovenous fistula stenosis in hemodialysis patients. Am J Kidney Dis. 2007;49(5):664-673. doi:10. 1053/j.ajkd.2007.02.266
25. Conte MS, Nugent HM, Gaccione P, Roy-Chaudhury P, Lawson JH. Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling. J Vasc Surg. 2011;54(5): 1383-1389. doi:10.1016/j.jvs.2011.05.005
26. Dammers R, Tordoir JHM, Kooman JP, et al. The effect of flow changes on the arterial system proximal to an arteriovenous fistula for hemodialysis. Ultrasound Med Biol. 2005;31(10):1327-1333. doi:10.1016/ j.ultrasmedbio.2005.03.017
27. Kharboutly Z, Fenech M, Treutenaere JM, Claude I, Legallais C. Investigations into the relationship between hemodynamics and vascular alterations in an established arteriovenous fistula. Med Eng Phys. 2007;29(9):999-1007. doi:10.1016/j.medengphy.2006.10.018
28. Kim JT, Chang WH, Oh TY, Jeong YK. Venous distensibility as a key factor in the success of arteriovenous fistulas at the wrist. Ann Vasc Surg. 2011;25(8):1094-1098. doi:10.1016/j.avsg.2011.05.014
29. Satoh M. Endothelial dysfunction as an underlying pathophysiological condition of chronic kidney disease. Clin Exp Nephrol. 2012;16(4):518-521. doi:10.1007/s10157-012-0646-y
30. Alexander RW. Hypertension and the pathogenesis of atherosclerosis. Hypertension. 1995;25(2):155-161. doi:10.1161/01.HYP.25.2.155
31. Truong A, Hanna MH, Moghadamyeghaneh Z, Stamos MJ. Implications of preoperative hypoalbuminemia in colorectal surgery. World J Gastrointest Surg. 2016;8(5):353-362. doi:10.4240/wjgs.v8.i5.353
32. Farrugia A. Albumin usage in clinical medicine: tradition or therapeutic? Transfus Med Rev. 2010;24(1):53-63. doi:10.1016/j.tmrv. 2009.09.005
33. Churchill DN, Taylor DW, Cook RJ, et al. Canadian hemodialysis morbidity study. Am J Kidney Dis. 1992;19(3):214-234. doi:10.1016/s0272-6386(13)80002-9
34. Chang CJ, Ko YS, Ko PJ, et al. Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity. Kidney Int. 2005;68(3):1312-1319. doi:10.1111/j.1523-1755.2005.00529.x
35. Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009; 158(4):659-666. doi:10.1016/j.ahj.2009.07.024
36. Wen Y. High red blood cell distribution width is closely associated with risk of carotid artery atherosclerosis in patients with hypertension. Exp Clin Cardiol. 2010;15(3):37-40.
37. Cardinal H, Raymond MA, Hébert MJ, Madore F. Uraemic plasma decreases the expression of ABCA1, ABCG1 and cell-cycle genes in human coronary arterial endothelial cells. Nephrol Dial Transplant. 2007;22(2):409-416. doi:10.1093/ndt/gfl619
38. Cowan DB, Langille BL. Cellular and molecular biology of vascular remodeling. Curr Opin Lipidol. 1996;7(2):94-100. doi:10.1097/00041433-199604000-00008
39. Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation. 2004;109(21 Suppl 1):II27-33. doi:10.1161/01.CIR.0000129501.88485.1f
40. Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood. 1997;89(7):2429-2442.
41. Schwartz BR, Karsan A, Bombeli T, Harlan JM. A novel beta 1 integrin-dependent mechanism of leukocyte adherence to apoptotic cells. J Immunol. 1999;162(8):4842-4848.
42. Raymond MA, Désormeaux A, Laplante P, et al. Apoptosis of endothelial cells triggers a caspase-dependent anti-apoptotic paracrine loop active on VSMC. FASEB J. 2004;18(6):705-707. doi:10.1096/fj.03-0573fje
43. Pearson JD. Vessel wall interactions regulating thrombosis. Br Med Bull. 1994;50(4):776-788. doi:10.1093/oxfordjournals.bmb.a072925
44. Biuckians A, Scott EC, Meier GH, Panneton JM, Glickman MH. The natural history of autologous fistulas as first-time dialysis access in the KDOQI era. J Vasc Surg. 2008;47(2):415-421. doi:10.1016/j.jvs.2007.10.041
45. Depboylu BC, Külcü N, Yolyapan DA. Retrospective analysis of arteriovenous fistulas for hemodialysis: our two-year clinical experience. Damar Cer Derg. 2014;23(2):67-71. doi:10.9739/uvcd.2014-41105